Aurobindo Pharma USA broke ground last week on a 567,000-square-foot facility in East Windsor
EAST WINDSOR -- Pharmaceutical company Aurobindo Pharma USA broke ground last week on a 567,000-square-foot facility in East Windsor that will become its new U.S. corporate headquarters.
The 90-acre campus on Windsor Center Drive will house a pharmaceutical warehouse, distribution and manufacturing center that is expected to generate new tax dollars and 400 to 500 jobs.
It also recently moved its administrative offices into the Patscentre building on Route 571.
"This is an exciting day as the size and scope of this facility marks a significant investment by Aurobindo in East Windsor Township," Mayor Janice Mironov said. "Aurobindo's selection of East Windsor ... underscores once again the tremendous attraction of the township for high-tech, high-growth research and development pharmaceutical-related companies."
The company, which is based in India, has a broad portfolio of generic drugs that includes more than 125 product families and 450 individual product packages.
Officials say that its expansion comes at a time of rapid growth for the company.
In the past year, it has received the highest number of final abbreviated new drug application approvals by the Food and Drug Administration among all of its competitors and ranks eighth among all generic pharmaceutical companies. The FDA recently approved its generic version of Tricor, which is used to lower cholesterol and triglyceride levels.
Cristina Rojas may be reached at crojas@njadvancemedia.com. Follow her on Twitter @CristinaRojasTT. Find NJ.com on Facebook.